Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
COMBO: Dexamethasone for Adhesion-Related Small Bowel Obstruction
NCT07084441Phase 4Recruiting
- Sponsor
- University of Washington
- Start
- Feb 2026
- Primary completion
- Jun 2030
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in Adhesive small bowel obstruction (ASBO) (2 arms), sponsored by University of Washington. Primary endpoint: Resolution of adhesive Small Bowel Obstruction at 30 days. Started Feb 2026; status: recruiting.
02
Drugs
dexamethasone
03
Conditions
Adhesive small bowel obstruction (ASBO)
Beyond the preview
Go deeper on NCT07084441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07084441.